Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 96

    2.

    A gamma-secretase inhibitor and quinacrine reduce prions and prevent dendritic degeneration in murine brains.

    Spilman P, Lessard P, Sattavat M, Bush C, Tousseyn T, Huang EJ, Giles K, Golde T, Das P, Fauq A, Prusiner SB, Dearmond SJ.

    Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10595-600. Epub 2008 Jul 22.

    PMID:
    18647832
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    Notch-1 activation and dendritic atrophy in prion disease.

    Ishikura N, Clever JL, Bouzamondo-Bernstein E, Samayoa E, Prusiner SB, Huang EJ, DeArmond SJ.

    Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):886-91. Epub 2005 Jan 7.

    PMID:
    15640354
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    4.

    Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells.

    Bate C, Tayebi M, Diomede L, Salmona M, Williams A.

    BMC Biol. 2008 Sep 12;6:39.

    PMID:
    18789130
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    5.

    Abnormal plasma membrane properties and functions in prion-infected cell lines.

    DeArmond SJ, Qiu Y, Wong K, Nixon R, Hyun W, Prusiner SB, Mobley WC.

    Cold Spring Harb Symp Quant Biol. 1996;61:531-40. Review.

    PMID:
    9246479
    [PubMed - indexed for MEDLINE]
    6.

    Cholesterol transporter ATP-binding cassette A1 (ABCA1) is elevated in prion disease and affects PrPC and PrPSc concentrations in cultured cells.

    Kumar R, McClain D, Young R, Carlson GA.

    J Gen Virol. 2008 Jun;89(Pt 6):1525-32.

    PMID:
    18474570
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    7.

    Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity.

    Telling GC, Parchi P, DeArmond SJ, Cortelli P, Montagna P, Gabizon R, Mastrianni J, Lugaresi E, Gambetti P, Prusiner SB.

    Science. 1996 Dec 20;274(5295):2079-82.

    PMID:
    8953038
    [PubMed - indexed for MEDLINE]
    8.

    Inhibitors of the mitogen-activated protein kinase kinase 1/2 signaling pathway clear prion-infected cells from PrPSc.

    Nordström EK, Luhr KM, Ibáñez C, Kristensson K.

    J Neurosci. 2005 Sep 14;25(37):8451-6.

    PMID:
    16162927
    [PubMed - indexed for MEDLINE]
    Free Article
    9.

    Prion-induced neuronal damage--the mechanisms of neuronal destruction in the subacute spongiform encephalopathies.

    Giese A, Kretzschmar HA.

    Curr Top Microbiol Immunol. 2001;253:203-17. Review.

    PMID:
    11417136
    [PubMed - indexed for MEDLINE]
    10.

    Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A2 activation.

    Bate C, Tayebi M, Williams A.

    BMC Biol. 2008 Feb 12;6:8.

    PMID:
    18269734
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    11.

    Prion encephalopathies of animals and humans.

    Prusiner SB.

    Dev Biol Stand. 1993;80:31-44. Review.

    PMID:
    8270114
    [PubMed - indexed for MEDLINE]
    12.

    Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cells.

    Rao SS, O'Neil J, Liberator CD, Hardwick JS, Dai X, Zhang T, Tyminski E, Yuan J, Kohl NE, Richon VM, Van der Ploeg LH, Carroll PM, Draetta GF, Look AT, Strack PR, Winter CG.

    Cancer Res. 2009 Apr 1;69(7):3060-8. Epub 2009 Mar 24.

    PMID:
    19318552
    [PubMed - indexed for MEDLINE]
    Free Article
    13.

    Prion peptide 106-126 as a model for prion replication and neurotoxicity.

    Singh N, Gu Y, Bose S, Kalepu S, Mishra RS, Verghese S.

    Front Biosci. 2002 Apr 1;7:a60-71.

    PMID:
    11897566
    [PubMed - indexed for MEDLINE]
    14.

    Tricyclic antidepressants, quinacrine and a novel, synthetic chimera thereof clear prions by destabilizing detergent-resistant membrane compartments.

    Klingenstein R, Löber S, Kujala P, Godsave S, Leliveld SR, Gmeiner P, Peters PJ, Korth C.

    J Neurochem. 2006 Aug;98(3):748-59. Epub 2006 Jun 2. Erratum in: J Neurochem. 2006 Sep;98(5):1696.

    PMID:
    16749906
    [PubMed - indexed for MEDLINE]
    15.

    Cell-lysate conversion of prion protein into its protease-resistant isoform suggests the participation of a cellular chaperone.

    Saborío GP, Soto C, Kascsak RJ, Levy E, Kascsak R, Harris DA, Frangione B.

    Biochem Biophys Res Commun. 1999 May 10;258(2):470-5.

    PMID:
    10329411
    [PubMed - indexed for MEDLINE]
    16.

    The AGAAAAGA palindrome in PrP is required to generate a productive PrPSc-PrPC complex that leads to prion propagation.

    Norstrom EM, Mastrianni JA.

    J Biol Chem. 2005 Jul 22;280(29):27236-43. Epub 2005 May 25.

    PMID:
    15917252
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    A receptor for infectious and cellular prion protein.

    Martins VR.

    Braz J Med Biol Res. 1999 Jul;32(7):853-9. Review.

    PMID:
    10454744
    [PubMed - indexed for MEDLINE]
    Free Article
    18.

    Novel mechanisms of degeneration of the central nervous system--prion structure and biology.

    Prusiner SB, Stahl N, DeArmond SJ.

    Ciba Found Symp. 1988;135:239-60. Review.

    PMID:
    2900720
    [PubMed - indexed for MEDLINE]
    19.

    [Physiopathology and molecular diagnosis for prion diseases].

    Katamine S.

    Rinsho Byori. 2000 May;48(5):437-41. Review. Japanese.

    PMID:
    10892292
    [PubMed - indexed for MEDLINE]
    20.

    Inhibition of gamma-secretase affects proliferation of leukemia and hepatoma cell lines through Notch signaling.

    Suwanjunee S, Wongchana W, Palaga T.

    Anticancer Drugs. 2008 Jun;19(5):477-86.

    PMID:
    18418214
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk